These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34535316)

  • 1. Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies.
    McNay LA; Arnoczy G; Martell M; Mock P; Wright ME; Simpson S; Smolskis M; Higgs ES
    Vaccine; 2021 Oct; 39(42):6183-6185. PubMed ID: 34535316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Partners Platform-Accelerating Response by Coordinating Plans, Needs, and Contributions During Public Health Emergencies: COVID-19 Vaccines Use Case.
    Shen AK; Yu MA; Lindstrand A; Baxi SM; Jousset O; O'Brien K; Boulanger L
    Glob Health Sci Pract; 2021 Dec; 9(4):725-732. PubMed ID: 34933970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationalizing Public Health Emergency Legal Responses.
    Hodge JG
    J Law Med Ethics; 2021; 49(2):315-320. PubMed ID: 34924048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper extremity emergencies during SARS-COV-2 pandemic: Turnout trends.
    Fyllos A; Varitimidis S; Papageorgiou F; Karamanis N; Alexiou K; Veloni A; Malizos K; Dailiana Z
    Injury; 2021 Mar; 52(3):387-394. PubMed ID: 33246643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COVID-19-designated hospitals in China: preparing for public health emergencies.
    Li Q; Wang L; Wang B; Lu H
    Emerg Microbes Infect; 2021 Dec; 10(1):998-1001. PubMed ID: 33993856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliance is key to effective access and oversight of medical products in case of public health emergencies.
    Saint-Raymond A; Valentin M; Nakashima N; Orphanos N; Santos G; Balkamos G; Azatyan S
    Expert Rev Clin Pharmacol; 2022 Jul; 15(7):805-810. PubMed ID: 35945703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responding to Covid-19: How to Navigate a Public Health Emergency Legally and Ethically.
    Gostin LO; Friedman EA; Wetter SA
    Hastings Cent Rep; 2020 Mar; 50(2):8-12. PubMed ID: 32219845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplying the pandemic response: The importance of public procurement.
    Abutabenjeh S; Anguelov L; Brunjes BM; Dimand AM; Rodriguez-Plesa E
    J Emerg Manag; 2021 Special Issue on COVID-19; 18(7):189-208. PubMed ID: 34723363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China.
    Wang X; Zhang X; He J
    Biosci Trends; 2020 Mar; 14(1):3-8. PubMed ID: 32062645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of state law in the public health emergency response to COVID-19: an example from Delaware in the United States.
    Goldstein ND; Suder JS
    J Public Health Policy; 2021 Mar; 42(1):167-175. PubMed ID: 32989234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The European Union and Public Health Emergencies: Expert Opinions on the Management of the First Wave of the COVID-19 Pandemic and Suggestions for Future Emergencies.
    Gontariuk M; Krafft T; Rehbock C; Townend D; Van der Auwermeulen L; Pilot E
    Front Public Health; 2021; 9():698995. PubMed ID: 34490183
    [No Abstract]   [Full Text] [Related]  

  • 12. The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials.
    Singh JA; Upshur REG
    Lancet Infect Dis; 2021 Apr; 21(4):e103-e109. PubMed ID: 33306980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the COVID-19 pandemic: lessons towards a more effective response to public health emergencies.
    Assefa Y; Gilks CF; Reid S; van de Pas R; Gete DG; Van Damme W
    Global Health; 2022 Feb; 18(1):10. PubMed ID: 35120537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [COVID-19: Warp Speed vaccines].
    Feraoun Y; Maisonnasse P; Le Grand R; Beignon AS
    Med Sci (Paris); 2021; 37(8-9):759-772. PubMed ID: 34080537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Government Information Dissemination During Public Health Emergencies: An Analysis of China's Experiences.
    Zhang Y; Shan J; Ye Z
    Front Public Health; 2022; 10():748236. PubMed ID: 35392466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pacing Forward in the Face of Fragility: Lessons From African Institutions and Governments' Response to Public Health Emergencies.
    Bitanihirwe B; Ssewanyana D; Ddumba-Nyanzi I
    Front Public Health; 2021; 9():714812. PubMed ID: 34900886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Panel Evaluation of the Changes in the General Public's Social-Media-Following of United States' Public Health Departments during COVID-19 Pandemic.
    Khokhar A; Spaulding A; Niazi Z; Ailawadhi S; Manochakian R; Chanan-Khan A; Niazi S; Sher T
    J Prim Care Community Health; 2021; 12():2150132721995450. PubMed ID: 33648364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Destigmatizing public health concerns and supply of COVID-19 vaccines.
    Akel S; Bleibel F; Hale G; Khanfar NM
    Health Mark Q; 2021; 38(2-3):91-97. PubMed ID: 34420472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Pandemic Response: Employing Mathematical Modeling to Confront Coronavirus Disease 2019.
    Biggerstaff M; Slayton RB; Johansson MA; Butler JC
    Clin Infect Dis; 2022 Mar; 74(5):913-917. PubMed ID: 34343282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pakistan's Response to COVID-19: Overcoming National and International Hypes to Fight the Pandemic.
    Akhtar H; Afridi M; Akhtar S; Ahmad H; Ali S; Khalid S; Awan SM; Jahangiri S; Khader YS
    JMIR Public Health Surveill; 2021 May; 7(5):e28517. PubMed ID: 33877048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.